I appreciate the opportunity to be able to present a company update on Ideal Power to you. My name is David Somo, President and CEO of Ideal Power. As many of you know, I joined the company in ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Northborne Partners today announced that it served as the exclusive financial advisor to Savage Enterprises LLC ("Savage") in connection with its announced execution of a definitive agreement to sell ...

Abstract: Existing current signal-based open-circuit fault diagnosis methods necessitate real-time analysis of extensive historical current data for fault feature extraction, which leads to large ...

Abstract: This study presents a scale-free and phase-agnostic method for detecting interturn short-circuit faults (ISCFs) in the stator windings of permanent magnet synchronous motors (PMSMs). The ...